Cosmecca Korea
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Cosmecca Korea formulates and manufactures skincare and colour cosmetics, products such as moisturisers, foundations, and BB creams, on behalf of domestic and international beauty brands, handling everything from product development to finished goods.
It operates as an ODM and OEM partner (meaning it develops or manufactures products to a client brand's specification), supplying a broad range of global cosmetics companies. Listed on KOSDAQ, Korea's tech and small-cap board, the company runs production facilities in Korea, China, and the United States. Roughly two-fifths of its workforce is dedicated to research and development, underpinning an active intellectual-property registration programme.
Summary is AI-generated and may contain errors · figures from DART filings
Cosmecca Korea acquired Englewood Lab, a New Jersey-based cosmetics manufacturer, giving it a direct US production base to serve North American brand clients.
Cosmecca Korea in five facts
What does Cosmecca Korea do?
Cosmecca Korea formulates and manufactures skincare and colour cosmetics, products such as moisturisers, foundations, and BB creams, on behalf of domestic and international beauty brands, handling everything from product development to finished goods.
Where is Cosmecca Korea listed and in which sector?
Cosmecca Korea (Korean name: 코스메카코리아) trades under KRX code 241710 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Materials sector, Chemicals.
How large is Cosmecca Korea?
Its market capitalisation was US$864.9M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Cosmecca Korea's latest annual revenue and operating profit?
For fiscal year 2025, Cosmecca Korea reported revenue of US$483.7M, operating profit of US$63.1M and net income of US$43.7M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was up 22.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on large shareholdings (5% rule) (abbreviated)Oct 20
- Shareholder register closure / record date setOct 13
- Resolution to convene a general shareholders' meeting (extraordinary meeting)Oct 13
- Shareholder register closure / record date setOct 6
- Report on securities held by executives/major shareholdersOct 6
- Report on large shareholdings (5% rule) (abbreviated)Oct 6
- Report on large shareholdings (5% rule) (abbreviated)Oct 2
- [Attachment amended] Material event report (merger)M&A · Sep 28
- [Amended] Material event report (merger)M&A · Sep 18 · 2 versions
- Report on large shareholdings (5% rule) (standard)Sep 16
- DisclosureSep 9
- Report on large shareholdings (5% rule) (abbreviated)Sep 2
- Investor relations (IR) meetingSep 1
- Operating results (consolidated) (preliminary) (fair disclosure)
Cosmecca Korea filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$160M (+39.8% year on year), operating profit of US$22.6M (+39.3% year on year) and net income of US$14.3M (+88% year on year).
Earnings · Aug 10 - Operating results (consolidated) (preliminary) (fair disclosure)
Cosmecca Korea filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$127M (+56.4% year on year), operating profit of US$15M (+78% year on year) and net income of US$13.5M (+112.8% year on year).
Earnings · May 8 - Cash/in-kind dividend decision
Cosmecca Korea declared a cash dividend of US$0.26 per share.
Dividend · Feb 20 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Cosmecca Korea reported consolidated results for FY2025: revenue of US$442M (+22.2% year on year), operating profit of US$57.6M (+38.1% year on year) and net income of US$39.7M (+7.1% year on year).
Earnings · Feb 20 - Operating results (consolidated) (preliminary) (fair disclosure)
Cosmecca Korea filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$123M (+38.8% year on year), operating profit of US$14.4M (+56.5% year on year) and net income of US$10.5M (−6.9% year on year).
Earnings · Feb 20